PINELLI ROBERTO has a total of 27 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are RONGXIANG XU, ALTIMMUNE INC and SOLVAY BIOLOGICALS BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Italy | 4 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Implantable devices | |
#5 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Pinelli Roberto | 27 |
Publication | Filing date | Title |
---|---|---|
WO2017130130A1 | Nutritional supplement for maintaining the state of health of the eye | |
US2019008832A1 | Compositions for the treatment of presbyopia | |
US2019010453A1 | Retinal stem cells | |
EP2590638A1 | Trans-epithelial osmotic collyrium for the treatment of keratoconus | |
US2010286156A1 | Collyrium For The Treatment Of Conical Cornea With Cross-Linking Trans-Epithelial Technique | |
EP2253321A1 | Collyrium for the treatment of conial cornea with "cross-linking" trans-epithelial technique | |
EP1773211A2 | Apparatus for correcting presbyopia |